Tag: applied genetic technologies

Applied Genetic Technologies Prepares Offering After Trial Data

The company faced a share price decline last week, but is still up over 50 percent so far in the...

Applied Genetic Technologies Announces Strategic Collaboration with Otonomy

The companies will develop a gene therapy for patients with a sensorineural hearing loss, which is a form of congenital...

5 Top NASDAQ Biotech and Pharma Stocks: Big Rise for Ovid Therapeutics

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...

Applied Genetic Technologies Announces Enrollments in Phase 1/2 Clinical Trials

Applied Genetic Technologies (NASDAQ:AGTC) has announced it has reached two milestones in two of its Phase 1/2 clinical trials. As...

AGTC Announces Topline Interim Six-Month Data from Phase 1/2 X-Linked Retinoschisis Clinical Study

Applied Genetic Technologies (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment...